In silico discovery of natural compound-derived multi-target inhibitor for Huntington’s disease therapy
Crossref DOI link: https://doi.org/10.1038/s41598-026-38430-w
Published Online: 2026-02-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zheng, Bo
Banday, Mehrukh
Gangwar, Shalesh
Abbas, Mohamed
Raza, Khalid
Text and Data Mining valid from 2026-02-07
Version of Record valid from 2026-02-26
Article History
Received: 26 September 2025
Accepted: 29 January 2026
First Online: 7 February 2026
Declarations
:
: The authors declare no competing interests.